1. Stimulation of fracture mineralization by salt-inducible kinase inhibitors
- Author
-
Kaveh Momenzadeh, Diana Yeritsyan, Mohammadreza Abbasian, Nadim Kheir, Philip Hanna, Jialiang Wang, Pere Dosta, Garyfallia Papaioannou, Sarah Goldfarb, Cheng-Chia Tang, Eliz Amar-Lewis, Michaela Nicole Prado Larrea, Edith Martinez Lozano, Mohamed Yousef, John Wixted, Marc Wein, Natalie Artzi, and Ara Nazarian
- Subjects
bone ,fracture repair ,nanoscale drug delivery ,SIK2/SIK3 inhibitor ,PTH ,siRNA targeting ,Biotechnology ,TP248.13-248.65 - Abstract
IntroductionOver 6.8 million fractures occur annually in the US, with 10% experiencing delayed- or non-union. Anabolic therapeutics like PTH analogs stimulate fracture repair, and small molecule salt inducible kinase (SIK) inhibitors mimic PTH action. This study tests whether the SIK inhibitor YKL-05-099 accelerates fracture callus osteogenesis.Methods126 female mice underwent femoral shaft pinning and midshaft fracture, receiving daily injections of PBS, YKL-05-099, or PTH. Callus tissues were analyzed via RT-qPCR, histology, single-cell RNA-seq, and μCT imaging. Biomechanical testing evaluated tissue rigidity. A hydrogel-based delivery system for PTH and siRNAs targeting SIK2/SIK3 was developed and tested.ResultsYKL-05-099 and PTH-treated mice showed higher mineralized callus volume fraction and improved structural rigidity. RNA-seq indicated YKL-05-099 increased osteoblast subsets and reduced chondrocyte precursors. Hydrogel-released siRNAs maintained target knockdown, accelerating callus mineralization.DiscussionYKL-05-099 enhances fracture repair, supporting selective SIK inhibitors’ development for clinical use. Hydrogel-based siRNA delivery offers targeted localized treatment at fracture sites.
- Published
- 2024
- Full Text
- View/download PDF